z-logo
open-access-imgOpen Access
Post Option B+ implementation programme in Nigeria: Determinants of adherence of antiretroviral therapy among pregnant women with HIV
Author(s) -
Olumuyiwa Omonaiye,
Snezana Kusljic,
Patricia Nicholson,
Mohammadreza Mohebbi,
Elizabeth Manias
Publication year - 2019
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2019.02.014
Subject(s) - medicine , logistic regression , odds ratio , confidence interval , cross sectional study , pregnancy , antiretroviral therapy , demography , human immunodeficiency virus (hiv) , odds , environmental health , family medicine , viral load , genetics , pathology , sociology , biology
Nigeria has the highest rate of mother to child transmission of HIV (MTCT) in the world. By 2015, all Global Plan priority countries, except Nigeria, had adopted the Option B+ programme. Nigeria finally adopted Option B+ in 2016 with full implementation reported in 2017. We examined adherence to antiretroviral therapy (ART) among pregnant women since the rollout of Option B+ in Nigeria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom